# A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma

> **NCT03809637** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 37 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Pemetrexed, cisplatin

## Key facts

- **NCT ID:** NCT03809637
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-10
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809637, "A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03809637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*